Stay updated on AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded Thromboangiitis obliterans to the resources list and included a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page; no visible changes to study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check25 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded page revision label: Revision: v3.4.2; removed the government-funding notice and prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedA government funding lapse notice was added and the site version updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded UI/metadata updates: a glossary toggle is shown, a 'Last Update Submitted that Met QC Criteria' label appears, the revision is updated to v3.4.0, and the deletions remove the older phrasing and lowercase 'No FEAR Act data' wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD5305+New Hormonal Agents in Metastatic Prostate Cancer Clinical Trial page.